Name | Upadacitinib | CAS# | 1310726-60-3 | |
---|---|---|---|---|
Price | ¥Inquiry/1g | Purity | 98.9% | |
Stocking Period |
1 Day | Stock | In Stock |
Detail
Product Information
Upadacitinib (ABT-494) is a potent and selective Janus kinase (JAK) 1 inhibitor being developed for the treatment of several autoimmune disorders with an IC50 of 43 nM. |
Get all suppliers by the below link:
2024-07-15 |
Upadacitinib
Price: Inquiry |
2019-03-05 |
Upadacitinib
Price: ¥916.0 |
2020-01-06 |
Upadacitinib
Price: $550.0 |
2021-07-26 |
Upadacitinib
Price: $Inquiry |
2024-01-09 |
Upadacitinib
Price: $Inquiry |
2023-09-13 |
Upadacitinib
Price: ¥Inquiry |
2024-05-31 |
Upadacitinib
Price: ¥Inquiry |
2024-01-04 |
Upadacitinib
Price: ¥450.0 |
2024-02-05 |
Upadacitinib
Price: ¥Inquiry |
Get all price from the following link:
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved